BDBM3181 2-[[2,6-Dihydroxy-4-[[2-[[(4-hydroxyphenyl)carbonyl]amino]ethoxy]carbonyl]phenyl]carbonyl]-3-hydroxybenzoic Acid::2-{[2,6-dihydroxy-4-({2-[(4-hydroxyphenyl)formamido]ethoxy}carbonyl)phenyl]carbonyl}-3-hydroxybenzoic acid::Acyclic Balanol Analog 3

SMILES OC(=O)c1cccc(O)c1C(=O)c1c(O)cc(cc1O)C(=O)OCCNC(=O)c1ccc(O)cc1

InChI Key InChIKey=AGFZKGRTVAVKSP-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 3181   

TargetProtein kinase C eta type(Human)
Sphinx Laboratories

LigandChemical structure of BindingDB Monomer ID 3181BDBM3181(2-[[2,6-Dihydroxy-4-[[2-[[(4-hydroxyphenyl)carbony...)
Affinity DataIC50: 230nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C delta type(Human)
Sphinx Laboratories

LigandChemical structure of BindingDB Monomer ID 3181BDBM3181(2-[[2,6-Dihydroxy-4-[[2-[[(4-hydroxyphenyl)carbony...)
Affinity DataIC50: 410nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandChemical structure of BindingDB Monomer ID 3181BDBM3181(2-[[2,6-Dihydroxy-4-[[2-[[(4-hydroxyphenyl)carbony...)
Affinity DataIC50: 4.50E+3nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C gamma type(Human)
Sphinx Laboratories

LigandChemical structure of BindingDB Monomer ID 3181BDBM3181(2-[[2,6-Dihydroxy-4-[[2-[[(4-hydroxyphenyl)carbony...)
Affinity DataIC50: 6.60E+3nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C beta type(Human)
Sphinx Laboratories

LigandChemical structure of BindingDB Monomer ID 3181BDBM3181(2-[[2,6-Dihydroxy-4-[[2-[[(4-hydroxyphenyl)carbony...)
Affinity DataIC50: 7.50E+3nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
LigandChemical structure of BindingDB Monomer ID 3181BDBM3181(2-[[2,6-Dihydroxy-4-[[2-[[(4-hydroxyphenyl)carbony...)
Affinity DataIC50: 8.40E+3nMpH: 7.5 T: 2°CAssay Description:The activity of PKA, activated by cAMP, is measured by its ability to transfer phosphate from [gamma-32P]ATP to histone.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C alpha type(Human)
Sphinx Laboratories

LigandChemical structure of BindingDB Monomer ID 3181BDBM3181(2-[[2,6-Dihydroxy-4-[[2-[[(4-hydroxyphenyl)carbony...)
Affinity DataIC50: 1.10E+4nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed
TargetProtein kinase C epsilon type(Human)
Sphinx Laboratories

LigandChemical structure of BindingDB Monomer ID 3181BDBM3181(2-[[2,6-Dihydroxy-4-[[2-[[(4-hydroxyphenyl)carbony...)
Affinity DataIC50: 1.30E+4nMpH: 7.5 T: 2°CAssay Description:PKC was assayed by quantitating the incorporation of 32P from [gamma-32P]ATP into histone type IIIs.More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/31/2005
Entry Details Article
PubMed